Drugs / ATNC05
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT01920087 | Mar 2014 → Mar 2016 | facial neuralgia, neuropathy, painful, persistent idiopathic facial pain, trigeminal neuralgia | Allodynic Therapeutics, Inc | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ATNC05 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01920087 ↗ |